Heartseedの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/07/04 | 2,695 | 2,866 | 2,693 | 2,774 | +84 | +3.1% | 956,900 |
2025/07/03 | 2,725 | 2,756 | 2,641 | 2,690 | -22 | -0.8% | 739,300 |
2025/07/02 | 2,675 | 2,778 | 2,610 | 2,712 | +15 | +0.6% | 902,400 |
2025/07/01 | 2,751 | 2,774 | 2,660 | 2,697 | +27 | +1% | 1,243,400 |
2025/06/30 | 2,634 | 2,749 | 2,617 | 2,670 | +55 | +2.1% | 954,400 |
2025/06/27 | 2,625 | 2,697 | 2,590 | 2,615 | -26 | -1% | 867,900 |
2025/06/26 | 2,687 | 2,762 | 2,612 | 2,641 | -48 | -1.8% | 1,232,300 |
2025/06/25 | 2,902 | 2,949 | 2,636 | 2,689 | -247 | -8.4% | 2,218,100 |
2025/06/24 | 3,140 | 3,175 | 2,919 | 2,936 | -194 | -6.2% | 1,079,800 |
2025/06/23 | 3,165 | 3,265 | 3,095 | 3,130 | -105 | -3.2% | 704,000 |
2025/06/20 | 3,285 | 3,395 | 3,165 | 3,235 | -65 | -2% | 1,240,500 |
2025/06/19 | 3,560 | 3,575 | 3,280 | 3,300 | -160 | -4.6% | 943,600 |
2025/06/18 | 3,720 | 3,770 | 3,365 | 3,460 | -205 | -5.6% | 1,674,300 |
2025/06/17 | 4,180 | 4,295 | 3,620 | 3,665 | -650 | -15.1% | 3,123,800 |
2025/06/16 | 3,820 | 4,385 | 3,760 | 4,315 | +565 | +15.1% | 4,051,600 |
2025/06/13 | 3,470 | 3,750 | 3,470 | 3,750 | +700 | +23% | 1,477,500 |
2025/06/12 | 3,090 | 3,165 | 3,025 | 3,050 | -50 | -1.6% | 734,800 |
2025/06/11 | 3,060 | 3,220 | 3,010 | 3,100 | +90 | +3% | 1,283,900 |
2025/06/10 | 2,984 | 3,010 | 2,932 | 3,010 | +60 | +2% | 882,600 |
2025/06/09 | 2,859 | 2,985 | 2,858 | 2,950 | +125 | +4.4% | 1,015,800 |
2025/06/06 | 2,820 | 2,829 | 2,765 | 2,825 | -13 | -0.5% | 539,200 |
2025/06/05 | 2,900 | 2,908 | 2,816 | 2,838 | -28 | -1% | 732,600 |
2025/06/04 | 2,901 | 2,935 | 2,835 | 2,866 | -12 | -0.4% | 950,400 |
2025/06/03 | 2,635 | 2,940 | 2,605 | 2,878 | +243 | +9.2% | 1,839,600 |
2025/06/02 | 2,625 | 2,648 | 2,573 | 2,635 | +9 | +0.3% | 372,100 |
2025/05/30 | 2,735 | 2,774 | 2,623 | 2,626 | -97 | -3.6% | 719,500 |
2025/05/29 | 2,773 | 2,815 | 2,712 | 2,723 | -3 | -0.1% | 687,600 |
2025/05/28 | 2,780 | 2,811 | 2,686 | 2,726 | -54 | -1.9% | 813,400 |
2025/05/27 | 2,754 | 2,820 | 2,695 | 2,780 | +59 | +2.2% | 1,078,500 |
2025/05/26 | 2,501 | 2,745 | 2,501 | 2,721 | +220 | +8.8% | 1,396,000 |
2025/05/23 | 2,545 | 2,638 | 2,472 | 2,501 | -79 | -3.1% | 639,100 |
2025/05/22 | 2,565 | 2,636 | 2,525 | 2,580 | -26 | -1% | 552,300 |
2025/05/21 | 2,590 | 2,645 | 2,523 | 2,606 | +64 | +2.5% | 933,400 |
2025/05/20 | 2,454 | 2,600 | 2,383 | 2,542 | +112 | +4.6% | 1,033,500 |
2025/05/19 | 2,406 | 2,510 | 2,392 | 2,430 | +11 | +0.5% | 684,000 |
2025/05/16 | 2,350 | 2,426 | 2,325 | 2,419 | +54 | +2.3% | 430,400 |
2025/05/15 | 2,319 | 2,392 | 2,291 | 2,365 | +35 | +1.5% | 469,500 |
2025/05/14 | 2,370 | 2,370 | 2,289 | 2,330 | -40 | -1.7% | 443,200 |
2025/05/13 | 2,381 | 2,476 | 2,364 | 2,370 | +34 | +1.5% | 748,900 |
2025/05/12 | 2,390 | 2,459 | 2,304 | 2,336 | -52 | -2.2% | 546,100 |
2025/05/09 | 2,390 | 2,463 | 2,363 | 2,388 | -22 | -0.9% | 592,700 |
2025/05/08 | 2,415 | 2,589 | 2,341 | 2,410 | +40 | +1.7% | 1,822,500 |
2025/05/07 | 2,595 | 2,602 | 2,360 | 2,370 | -153 | -6.1% | 1,142,900 |
2025/05/02 | 2,630 | 2,672 | 2,468 | 2,523 | -114 | -4.3% | 1,520,000 |
2025/05/01 | 2,546 | 2,769 | 2,528 | 2,637 | +77 | +3% | 3,346,400 |
2025/04/30 | 2,215 | 2,680 | 2,207 | 2,560 | +370 | +16.9% | 2,359,700 |
2025/04/28 | 2,116 | 2,224 | 2,104 | 2,190 | +66 | +3.1% | 457,700 |
2025/04/25 | 2,092 | 2,194 | 2,076 | 2,124 | +18 | +0.9% | 345,000 |
2025/04/24 | 2,125 | 2,155 | 2,067 | 2,106 | -33 | -1.5% | 420,000 |
2025/04/23 | 2,152 | 2,186 | 2,117 | 2,139 | +3 | +0.1% | 381,900 |
51~
100
件表示中 / 278件
類似銘柄と比較する
現在ご覧いただいている「ハートシード」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ハートシード | 346,000円 | +246.7% | - | 0.00% | 736.17倍 | 10.48倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
杏林製薬 | 153,300円 | -2.4% | -52.3% | 3.72% | 18.34倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 99,800円 | +20.3% | - | 0.00% | 176.95倍 | 1.38倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 63,200円 | +14.3% | - | 3.16% | 25.69倍 | 1.64倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 238,500円 | +16.9% | +33.2% | 2.31% | 13.03倍 | 1.03倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム